Palisade Bio Granted New U.S. Patent Covering Protease Inhibitor LB1148 for Treating Adhesions and Postoperative Ileus
December 08, 2021 08:00 ET
|
Palisade Bio, Inc.
Issuance of Additional U.S. Patent No11,202,768 Further Bolsters Palisade Bio’s Patent Portfolio The Company Continues to Advance LB1148 for Key Indications After LB1148 Topline Efficacy Results from...
Skinopathy Files Provisional Patent for Artificial Intelligence and Augmented Reality Powered Technology that will Guide Skin Cancer Surgeries
February 02, 2021 10:30 ET
|
Skinopathy
TORONTO, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Skinopathy, a Canadian medical company founded in 2020, has filed a provisional patent with the United States Patent and Trademark Office (USPTO) for...
Liquidia Announces Notice of Allowance for U.S. Patent Application Covering Methods of Treating Pulmonary Hypertension with Dry Powder Treprostinil
August 28, 2020 07:15 ET
|
Liquidia Technologies, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 28, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company focused on the development and...